Intellia Therapeutics Inc (NTLA)
R&D Expenses
$346.73M
TTM · Period ending: · USD
NTLA R&D Expenses
Latest reported$346.73Mperiod ending
Latest reported$346.73Mperiod ending
NTLA R&D Expenses ($10.74M → $346.73M)
Annual R&D Expenses
High-resolution chart · PNG
NTLA r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 388,861,000 | |
| 466,311,000 | |
| 435,069,000 | |
| 419,979,000 | |
| 229,807,000 | |
| 150,408,000 | |
| 108,413,000 | |
| 89,115,000 | |
| 67,647,000 | |
| 31,840,000 | |
| 11,170,000 | |
| 10,740,000 |